BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38505696)

  • 1. The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases.
    Roach M; Land N; Hernandez J; Rau R; Chou JW; Hickson SS; Rollmann DF; Maclean JR
    Int J Clin Pract; 2024; 2024():5877687. PubMed ID: 38505696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline for the management of chronic obstructive pulmonary disease--2011 update.
    Abdool-Gaffar MS; Ambaram A; Ainslie GM; Bolliger CT; Feldman C; Geffen L; Irusen EM; Joubert J; Lalloo UG; Mabaso TT; Nyamande K; O'Brien J; Otto W; Raine R; Richards G; Smith C; Stickells D; Venter A; Visser S; Wong M;
    S Afr Med J; 2011 Jan; 101(1 Pt 2):63-73. PubMed ID: 21526617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An estimate of rate of deviation from NCCN guideline recommendations for central nervous system imaging in trials forming basis for drug approval in first line advanced non-small cell lung cancer (NSCLC).
    Sharp J; Prasad V
    BMC Cancer; 2022 Jan; 22(1):70. PubMed ID: 35034621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.
    Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC
    Med J Aust; 2021 Oct; 215 Suppl 7():S3-S32. PubMed ID: 34601742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Educational interventions for health professionals managing chronic obstructive pulmonary disease in primary care.
    Cross AJ; Thomas D; Liang J; Abramson MJ; George J; Zairina E
    Cochrane Database Syst Rev; 2022 May; 5(5):CD012652. PubMed ID: 35514131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Practice Guideline: Sudden Hearing Loss (Update) Executive Summary.
    Chandrasekhar SS; Tsai Do BS; Schwartz SR; Bontempo LJ; Faucett EA; Finestone SA; Hollingsworth DB; Kelley DM; Kmucha ST; Moonis G; Poling GL; Roberts JK; Stachler RJ; Zeitler DM; Corrigan MD; Nnacheta LC; Satterfield L; Monjur TM
    Otolaryngol Head Neck Surg; 2019 Aug; 161(2):195-210. PubMed ID: 31369349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Practice Guideline: Sudden Hearing Loss (Update).
    Chandrasekhar SS; Tsai Do BS; Schwartz SR; Bontempo LJ; Faucett EA; Finestone SA; Hollingsworth DB; Kelley DM; Kmucha ST; Moonis G; Poling GL; Roberts JK; Stachler RJ; Zeitler DM; Corrigan MD; Nnacheta LC; Satterfield L
    Otolaryngol Head Neck Surg; 2019 Aug; 161(1_suppl):S1-S45. PubMed ID: 31369359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based management approaches for patients with severe chronic obstructive pulmonary disease (COPD): A practice review.
    Fu Y; Chapman EJ; Boland AC; Bennett MI
    Palliat Med; 2022 May; 36(5):770-782. PubMed ID: 35311415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
    J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inpatient medical rehabilitation in diabetes mellitus in light of evidence based practice guidelines: an evaluation on the basis of BfA routine data].
    Ganten JU; Raspe HH
    Rehabilitation (Stuttg); 2003 Apr; 42(2):94-108. PubMed ID: 12701002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
    Perera PN; Guy MC; Sweaney AM; Boesen KP
    J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.
    Schneider BJ; Daly ME; Kennedy EB; Antonoff MB; Broderick S; Feldman J; Jolly S; Meyers B; Rocco G; Rusthoven C; Slotman BJ; Sterman DH; Stiles BM
    J Clin Oncol; 2018 Mar; 36(7):710-719. PubMed ID: 29106810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians.
    Salinas GD; Williamson JC; Kalhan R; Thomashow B; Scheckermann JL; Walsh J; Abdolrasulnia M; Foster JA
    Int J Chron Obstruct Pulmon Dis; 2011; 6():171-9. PubMed ID: 21468169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany.
    Glaab T; Vogelmeier C; Hellmann A; Buhl R
    Int J Chron Obstruct Pulmon Dis; 2012; 7():101-8. PubMed ID: 22371651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of changes in guidelines for medication management of stable chronic obstructive pulmonary disease.
    Lin FJ; Lee TA; Wong PS; Pickard AS
    J Eval Clin Pract; 2013 Oct; 19(5):953-60. PubMed ID: 22892033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review.
    Zhang Z; Yang S; Ma Y; Zhou H; Wu X; Han J; Hou J; Hao L; Spicer JD; Koh YW; Provencio M; Reguart N; Mitsudomi T; Wang Q
    Transl Lung Cancer Res; 2021 Jun; 10(6):2715-2732. PubMed ID: 34295672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
    Hanna N; Johnson D; Temin S; Baker S; Brahmer J; Ellis PM; Giaccone G; Hesketh PJ; Jaiyesimi I; Leighl NB; Riely GJ; Schiller JH; Schneider BJ; Smith TJ; Tashbar J; Biermann WA; Masters G
    J Clin Oncol; 2017 Oct; 35(30):3484-3515. PubMed ID: 28806116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.